Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 01/31/32
Due: 01/31/33
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 11/30/13
End: 09/30/14
Due: 09/30/15
Phase: N/A
Priority: Normal
Start: 04/01/23
End: 08/31/25
Due: 08/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| International Severe CRSwNP Registry 2024-2028 | NCT06617754 | Vibeke Backer | user2@example.com | None | 2025-03-31 | 2032-01-31 | 2033-01-31 | - | - | 2025-07-14 |
| Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment | NCT02233231 | Vibeke Backer | user2@example.com | None | 2011-08-31 | 2013-05-31 | 2014-05-31 | - | - | 2025-07-14 |
| The Influence of Exercise and Hydration to the Pharmacological Response to Inhaled Terbutalin and Salbutamol in Men | NCT05749523 | Vibeke Backer | user2@example.com | None | 2013-11-30 | 2014-09-30 | 2015-09-30 | - | - | 2025-07-14 |
| Mepolizumab to CRSwNP Through 12 Months - Randomised to FESS and Non-FESS Within the First 2 Weeks | NCT05598814 | Vibeke Backer | user2@example.com | None | 2023-04-01 | 2025-08-31 | 2026-08-31 | - | - | 2025-07-14 |